We next applied our targeting and data analysis strategy to a BCR::ABL1-positive B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patient sample at first diagnosis (Fig. 7g, Supplementary Fig. 19b, Supplementary Table 1 and Supplementary Data 1). The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.